top stories

Sanofi sees downtick in flu sales as it preps for launch of RSV an­ti­body

10 hours ago
Pharma

In show­down with Roche, Re­gen­eron gears up for po­ten­tial Eylea ex­pan­sion amid Covid de­cline

10 hours ago
Pharma

Te­va drops out of in­dus­try trade group PhRMA

9 hours ago
Pharma

Latest

Most read

In­com­ing Roche CEO builds out his top team, tap­ping Genen­tech vet to lead phar­ma di­vi­sion

Yesterday
People
Pharma

Take­da fo­cus­es on ‘di­verse’ pipeline prospects on heels of two ac­qui­si­tions

10 hours ago
Pharma

In­fla­tion re­bates in­com­ing: Wyden calls on CMS to move quick­ly as No­var­tis CEO pledges re­ver­sal

10 hours ago
Pharma
Law

BeiGene re­veals men­tal health and can­cer care gap in study, de­buts dig­i­tal re­sources

10 hours ago
Pharma
Marketing
see latest stream
People

Neu­rode­gen­er­a­tive biotech Vyant warns of po­ten­tial wind-down

15 hours ago

Cana­di­an plant-based vac­cine de­vel­op­er Med­ica­go shut­ters months af­ter lay­offs

18 hours ago

J&J’s Janssen lays off em­ploy­ees at Penn­syl­va­nia, New Jer­sey sites

Yesterday
Financing

Be­hind Fri­day's $161M IPO: A star sci­en­tist, GPCR drug dis­cov­ery and a plan to chal­lenge phar­ma in di­a­betes

18 hours ago

Roivant, Ve­ra seek $100M+ rais­es as they look to fund drug hope­fuls

Yesterday

KKR health­care vet Jim Mom­tazee’s in­vest­ment firm clos­es $3.9B in­au­gur­al fund

2 days ago
Startups

Parthenon Ther­a­peu­tics CEO ex­its weeks af­ter co-founder leaves

Yesterday

'Moon­shot' at liv­er cell ther­a­py biotech Am­bys Med­i­cines comes to an end

2 days ago

Vec­tor Bio­Med launch­es with $15M to pro­duce back­logged CAR-T com­po­nent

3 days ago
Deals

Karuna li­cens­es Goldfinch as­sets to com­pete with Boehringer In­gel­heim in neu­ro­science

Yesterday

Gilead quash­es mi­cro­cap biotech's hope of part­ner­ing on oral Covid-19 drug

3 days ago

UniQure cash­es out $10M up­front to get can­di­date for in­her­it­ed ALS

3 days ago

Premium storiesSee all

#JPM23: Is 2023 go­ing to be a bet­ter year for biotech deal­mak­ing?

Yesterday

Q&A: No­vo Nordisk mar­ket­ing chief aims to change the con­ver­sa­tion around obe­si­ty, even as so­ci­ety has its own plans

3 days ago
Pharma
Marketing

No­var­tis' Xo­lair suc­ces­sor hit by an­oth­er PhI­II axe, but food al­ler­gy study con­tin­ues

3 days ago
R&D
Pharma

#JPM23: Reg­u­la­to­ry un­cer­tain­ty? What about M&A? Da­ta rule? Alessan­dro Masel­li and John Car­roll take out their crys­tal ...

4 days ago

In FocusSee all

A stem cell pi­o­neer sent an ex­per­i­ment in­to space. Pa­tients are the next fron­tier

Last week
People
Cell/Gene Tx

The con­fer­ence is back. What about the in­dus­try? Tak­ing the biotech pulse at #JPM23

3 weeks ago
Financing

As mon­ey pours in­to dig­i­tal ther­a­peu­tics, in­sur­ance cov­er­age crawls

2 months ago
R&D

Covid-19 spurred a his­toric vac­cine R&D ef­fort. What does it mean for fu­ture pan­demics?

3 months ago
R&D
Coronavirus

Don't missSee all

Gilead com­bines ar­ti­fi­cial in­tel­li­gence and art to draw at­ten­tion and hope to MBC

11 hours ago
Pharma
Marketing

FDA places hold on 4D Mol­e­c­u­lar’s Fab­ry gene ther­a­py

14 hours ago
Cell/Gene Tx
FDA+

Sanofi scraps PhI­II tri­al for Prin­cip­ia drug af­ter re­view­ing com­pe­ti­tion

18 hours ago
R&D
Pharma

Af­ter 13 years, Ramy Mah­moud steps in­to CEO seat at Opti­nose; Ru­pert Vessey set to ex­it Bris­tol My­ers in Ju­ly

18 hours ago
Peer Review

Endpoints Standouts

Sci­en­tists are fi­nal­ly learn­ing how to de­sign pro­teins from scratch. Drug de­vel­op­ment may nev­er be the same

8 months ago
People
Discovery

The 20(+1) un­der 40: Your guide to the next gen­er­a­tion of biotech lead­ers

9 months ago
Special

The 2022 top 100 bio­phar­ma in­vestors: A look back on boom times

11 months ago
Financing
Deals

Spe­cial re­port: Meet 20 ex­tra­or­di­nary women who are su­per­charg­ing bio­phar­ma R&D

Last year
People
Special

Peer review See all

Jan
27

Ex­clu­sive: Cell ther­a­py biotech brings on Loxo vet amid glob­al ex­pan­sion plans; Re­tire­ment beck­ons for Vir's George ...

Jan
20

'Per­fect time': SIGA's CEO on re­tire­ment; Ju­ve­nes­cence woos GSK vet to lead an­ti-ag­ing play

Jan
13

No­vavax and Cure­Vac among sev­er­al biotechs with new CEOs; Michel Vounatsos, John Tsai land board ap­point­ments

Jan
6

Bio­gen names de­vel­op­ment chief as it braces for lecanemab de­ci­sion; Zymeworks CMO is shown the door

Dec
22

Alex Hard­ing to chase in­dus­try dreams at CRISPR Ther­a­peu­tics; Scoop: Bio­gen’s head of busi­ness de­vel­op­ment splits ...

Pharma channel feed

5 days ago

Am­gen lays off about 300 work­ers, cit­ing 'in­dus­try head­wind­s'

Am­gen has laid off about 300 em­ploy­ees, a com­pa­ny spokesper­son con­firmed to End­points News via email Sun­day night.

READ MORE

Bris­tol My­ers turns at­ten­tion to new prod­ucts in wake of Revlim­id patent loss

Yesterday

Mer­ck’s Keytru­da nears $21B in sales, dou­bles down on com­bo tri­als

Yesterday
latest in Pharma

Gilead boasts its best growth since 2015 de­spite plung­ing sales of Covid treat­ment

19 hours ago

Eli Lil­ly touts sky­rock­et­ing Moun­jaro pre­scrip­tions even as it re­ports an over­all slump in 2022 rev­enue

Yesterday

Roche writes off $3B+ in pipeline as­sets, $750M for Spark-ac­quired gene ther­a­pies

Yesterday

BioN­Tech opens new plas­mid DNA man­u­fac­tur­ing fa­cil­i­ty in Ger­many

Yesterday
Cell/Gene Tx
Manufacturing

FDA ap­proves GSK's ane­mia drug with safe­ty warn­ing — af­ter bat­ting back sim­i­lar drugs

Yesterday
FDA+
see latest stories

Marketing channel feed

2 days ago

No­vo Nordisk notch­es big GLP-1 sales amid re­bound­ing sup­plies, but cau­tions on fu­ture 'pe­ri­od­ic con­straints'

With No­vo Nordisk’s obe­si­ty treat­ment We­govy ful­ly back in stock in De­cem­ber, sales are be­gin­ning to soar, the Dan­ish phar­ma re­port­ed dur­ing its an­nu­al earn­ings call on Wednes­day. To­tal ...

READ MORE

Pfiz­er scores high­est spend­ing dur­ing NFL sea­son among phar­ma ad­ver­tis­ers — iS­pot analy­sis

3 days ago
Pharma

J&J’s Janssen ‘Blue Jack­et’ fash­ion show re­turns to run­way for prostate can­cer aware­ness

Yesterday
Pharma
latest in Marketing

City of Hope re­brands ac­quired Can­cer Treat­ment Cen­ters of Amer­i­ca net­work un­der its own name

2 days ago
Pharma

Mar­ket­ingRx roundup: Pub­li­cis takes can­cer work­place ef­fort to Su­per Bowl; Phar­ma ad­ver­tis­ers still spend big on TV

3 days ago
Pharma

Roche’s Genen­tech de­buts next it­er­a­tion of MS cam­paign, high­lights ex­pe­ri­ences in Black com­mu­ni­ty

4 days ago
Pharma

UCB, No­vo Nordisk, Gilead rank high­est among phar­mas for HCP cus­tomer ex­pe­ri­ence — sur­vey

Last week
Pharma

'Tis the sea­son: GSK ad­dress­es win­ter virus surges with celebri­ty and in­flu­encer vac­cine aware­ness cam­paigns

Last week
Pharma
see latest stories

FDA+ channel feed

14 hours ago

Trodelvy notch­es a win in most com­mon form of breast can­cer

Fol­low­ing a promise last year to go “big and fast in breast can­cer,” Gilead has se­cured a win for Trodelvy in the most com­mon form.

READ MORE

FDA ax­es re­quire­ment for pos­i­tive Covid test be­fore Paxlovid use

2 days ago
Coronavirus

Pan­dem­ic wait is over: FDA be­gins tran­si­tion to in-per­son meet­ings in March

3 days ago
latest in FDA+

Pfiz­er brings Ibrance to new sub­set of breast can­cer pa­tients, re­gard­less of menopausal sta­tus

2 days ago
Pharma

Amid ap­pli­ca­tion tsuna­mi, FDA's top cell and gene ther­a­py leader to re­tire in March

3 days ago
People

Covid pub­lic health emer­gen­cies to end in May, but FDA's EUA au­thor­i­ty will con­tin­ue

3 days ago
Pharma
Coronavirus

Or­a­cle ex­ec­u­tive Troy Tazbaz named new FDA di­rec­tor of dig­i­tal health

4 days ago
People
Pharma

FDA ap­proves Italy-based phar­ma's oral SERD for some breast can­cer pa­tients

4 days ago
see latest stories

Manufacturing channel feed

Yesterday

Man­u­fac­tur­ing roundup: Catal­ent caps off man­u­fac­tur­ing site in Bel­gium; Eu­roAPI restarts pro­duc­tion in Hun­gary

Catal­ent is open­ing the doors to a new plas­mid DNA man­u­fac­tur­ing site at one of its core sites in Eu­rope.

READ MORE

Af­ter a busy year of build­outs, Ther­mo Fish­er sets plans for growth in 2023

2 days ago
Pharma

New com­peti­tors push Sanofi to of­fer vol­un­tary re­tire­ment pack­ages at two In­di­an sites

3 days ago
People
Pharma
latest in Manufacturing

Charles Riv­er se­cures $50M ac­qui­si­tion of drug dis­cov­ery tech com­pa­ny

4 days ago
Deals

Bris­tol My­ers, Charles Riv­er join Se­ries A fund­ing for iVex­Sol

Last week
Financing
Pharma

Up­dat­ed: Sam­sung Bi­o­log­ics spells out ex­pan­sion plans in South Ko­rea and US

Last week
Pharma

FDA takes next step in Tor­rent Phar­ma­ceu­ti­cal­s' trou­bled In­dia plant saga, is­sues OAI

Last week
Pharma
FDA+

Man­u­fac­tur­ing roundup: AGC Bi­o­log­ics to man­u­fac­ture di­a­betes ther­a­py; Cam­brex caps ac­qui­si­tion of Snap­drag­on Chem­istry

Last week
see latest stories